A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers
Clinical trial NCT03530514 · COMPLETED
Trial details
- NCT number
- NCT03530514
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2020-01-27
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.